3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Malignant Peripheral Nerve Sheath Tumors
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Leukemia, Myelomonocytic, Chronic
1
GATA2 Deficiency
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
12
Rituximab
10
obinutuzumab
6
fludarabine phosphate
6
Prednisone
6
fludarabine
5
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Melphalan
5
Magnetic Resonance Spectroscopy
5
Lenalidomide
5
Etoposide
5
Biopsy
5
tocilizumab
4
ibrutinib
4
Whole-Body Irradiation
4
Doxorubicin
4
venetoclax
3
polatuzumab vedotin
3
glofitamab
3
Mycophenolic Acid
3
Leukapheresis
3
Filgrastim
3
Cytarabine
3
Cyclosporine
3
Busulfan
3
Bendamustine Hydrochloride
3
ulixertinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
Vorinostat
×
30 days
×
Clear all
No trials found.